Immupharma PLC Holding(s) in Company (9563S)

TIDMIMM

RNS Number : 9563S

Immupharma PLC

29 December 2016

 
 RNS : FOR IMMEDIATE RELEASE   29 DECEMBER 2016 
 

ImmuPharma PLC

("ImmuPharma" or the "Company")

TR1 NOTIFICATION OF MAJOR INTEREST

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, announces that it has received a TR-1 by Lanstead Capital LP ("Lanstead"). Lanstead's holding in ImmuPharma is now confirmed at a total of 7,421,555 Ordinary Shares which equates to a current position in the Company of 5.95% of the 124,638,362 total voting rights.

Full disclosure of the TR1 is shown below:

-Ends-

 
 For further information please 
  contact: 
                                            + 44 (0) 20 
   ImmuPharma plc (www.immupharma.org)       7152 4080 
   Tim McCarthy, Chairman 
   Lisa Baderoon, Head of Investor 
    Relations                             + 44 (0) 7721 
    Twitter: @immupharma                   413496 
 
    Panmure, Gordon & Co., (NOMAD            +44 (0) 20 
    & Broker)                                7886 2500 
   Freddy Crossley, Duncan Monteith, 
    Corporate Finance 
    Charles Leigh-Pemberton, Corporate 
    Broking 
 
 
    Northland Capital Partners Limited 
    (Joint Broker) 
    Patrick Claridge, David Hignell, 
    Corporate Finance 
    Rob Rees, John Howes, Corporate        [phone] 
    Broking                                     6631 
 
 
 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
----------------------------------------------------------------------------------- 
 
 1. Identity of the issuer or                                    Immupharma plc 
  the underlying issuer 
  of existing shares to which 
  voting rights are 
  attached: (ii) 
-----------------------------------------------------------  ---------------------- 
 2 Reason for the notification (please tick the appropriate 
  box or boxes): 
----------------------------------------------------------------------------------- 
 An acquisition or disposal of voting rights                                      x 
------------------------------------------------------------------------------- 
 An acquisition or disposal of qualifying financial 
  instruments which may result in the acquisition 
  of shares already issued to which voting rights 
  are attached 
------------------------------------------------------------------------------- 
 An acquisition or disposal of instruments with 
  similar economic effect to qualifying financial 
  instruments 
------------------------------------------------------------------------------- 
 An event changing the breakdown of voting rights 
------------------------------------------------------------------------------- 
 Other                                                       (please specify): 
----------------------------------------------------------  ------------------- 
 3. Full name of person(s)                                     Lanstead Capital LP 
  subject to the 
  notification obligation: 
  (iii) 
-----------------------------------------------------------  ---------------------- 
 4. Full name of shareholder(s) 
  (if different from 3.):(iv) 
-----------------------------------------------------------  ---------------------- 
 5. Date of the transaction                                     28 December 2016 
  and date on 
  which the threshold is 
  crossed or 
  reached: (v) 
-----------------------------------------------------------  ---------------------- 
 6. Date on which issuer                                        28 December 2016 
  notified: 
-----------------------------------------------------------  ---------------------- 
 7. Threshold(s) that is/are 
  crossed or 
  reached: (vi, vii)                                               8%, 7%, 6% 
-----------------------------------------------------------  ---------------------- 
 
 
 
 8. Notified details: 
---------------------------------------------------------------------------------------------------------------------- 
 A: Voting rights attached to shares (viii, ix) 
---------------------------------------------------------------------------------------------------------------------- 
 Class/type     Situation previous                Resulting situation after the 
  of             to the triggering                 triggering transaction 
  shares         transaction 
 
  if possible 
  using 
  the ISIN 
  CODE 
-------------  --------------------------------  --------------------------------------------------------------------- 
                Number           Number           Number          Number of                   % of voting 
                 of               of               of shares       voting                      rights (x) 
                 Shares           Voting                           rights 
                                  Rights 
-------------  ---------------  ---------------  --------------  --------------------------  ------------------------- 
                                                  Direct          Direct        Indirect      Direct        Indirect 
                                                                   (xi)          (xii) 
-------------      -----------    -----------    --------------  ------------  ------------  ------------  ----------- 
 GB0033711010   10,521,555       10,521,555       7,421,555       7,421,555                   5.95% 
               ---------------  ---------------  --------------  ------------  ------------  ------------  ----------- 
 
 
 B: Qualifying Financial Instruments 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of            Expiration     Exercise/                        Number of voting              % of voting 
 financial           date           Conversion                       rights that                   rights 
 instrument          (xiii)         Period (xiv)                     may be 
                                                                     acquired if 
                                                                     the 
                                                                     instrument 
                                                                     is 
                                                                     exercised/ 
                                                                     converted. 
-----------------  -------------  -------------------------------  ----------------------------  --------------------- 
       N/A 
-----------------  -------------  -------------------------------  ----------------------------  --------------------- 
 
 C: Financial Instruments with similar economic effect 
  to Qualifying Financial Instruments (xv, xvi) 
---------------------------------------------------------------------------------------------------------------------- 
 Resulting situation after the triggering transaction 
---------------------------------------------------------------------------------------------------------------------- 
 Type of          Exercise       Expiration     Exercise/         Number of voting              % of voting 
 financial         price         date           Conversion         rights instrument             rights (xix, 
 instrument                      (xvii)         period             refers to                     xx) 
                                                (xviii) 
---------------  -------------  -------------  ----------------  ----------------------------  ----------------------- 
      N/A                                                                                       Nominal       Delta 
---------------  -------------  -------------  ----------------  ----------------------------  ------------  --------- 
 
 
 Total (A+B+C) 
---------------------------------------------------------------------------------------------------------------------- 
 Number of voting rights                            Percentage of voting rights 
-------------------------------------------------  ------------------------------------------------------------------- 
 7,421,555                                          5.95% 
-------------------------------------------------  ------------------------------------------------------------------- 
 
 
 
 9. Chain of controlled undertakings through which the 
  voting rights and/or the 
  financial instruments are effectively held, if applicable: 
  (xxi) 
---------------------------------------------------------------------------------------- 
 
   N/A 
 
 Proxy Voting: 
---------------------------------------------------------------------------------------- 
 10. Name of the proxy holder: 
-------------------------------------------------------------  ------------------------- 
 11. Number of voting rights proxy 
  holder will cease 
  to hold: 
-------------------------------------------------------------  ------------------------- 
 12. Date on which proxy holder will 
  cease to hold 
  voting rights: 
-------------------------------------------------------------  ------------------------- 
 
 
  13. Additional information: 
-------------------------------------------------------------  ------------------------- 
 14. Contact name:                                              Lisa De Vargas, Lanstead 
                                                                Partners Limited 
-------------------------------------------------------------  ------------------------- 
 15. Contact telephone number:                                  [phone] 
-------------------------------------------------------------  ------------------------- 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBKLFLQLFEFBL

(END) Dow Jones Newswires

December 29, 2016 05:54 ET (10:54 GMT)